These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol. Newbold RR; Hanson RB; Jefferson WN; Bullock BC; Haseman J; McLachlan JA Carcinogenesis; 2000 Jul; 21(7):1355-63. PubMed ID: 10874014 [TBL] [Abstract][Full Text] [Related]
7. Urinary tract evaluation of diethylstilbestrol-exposed female progeny followed in a colposcopy clinic. Gallup DG; Altaffer LF; Castle CA J Reprod Med; 1984 Oct; 29(10):717-21. PubMed ID: 6512780 [TBL] [Abstract][Full Text] [Related]
8. Diethylstilbestrol (DES) Pregnancy Treatment: A Promising Widely Used Therapy with Unintended Adverse Consequences. Herbst AL; Anderson D AMA J Ethics; 2015 Sep; 17(9):865-70. PubMed ID: 26390210 [No Abstract] [Full Text] [Related]
9. Teratogenic effects of intrauterine exposure to DES in female offspring. Nordqvist SR; Medhat IA; Ng AB Compr Ther; 1979 Sep; 5(9):69-74. PubMed ID: 487745 [No Abstract] [Full Text] [Related]
10. Cervical stenosis following minor gynecologic procedures on DES-exposed women. Schmidt G; Fowler WC Obstet Gynecol; 1980 Sep; 56(3):333-5. PubMed ID: 7422172 [TBL] [Abstract][Full Text] [Related]
11. Effects of prenatal maternal estrogen on the male urogenital system. Driscoll SG; Taylor SH Obstet Gynecol; 1980 Nov; 56(5):537-42. PubMed ID: 7432722 [TBL] [Abstract][Full Text] [Related]
12. Adverse pregnancy outcome: sensitive periods, types of adverse outcomes, and relationships with critical exposure periods. Kochenour NK Prog Clin Biol Res; 1984; 160():229-35. PubMed ID: 6382329 [TBL] [Abstract][Full Text] [Related]
13. [Exposure to diethylstilbestrol during pregnancy as a cause for developmental abnormalities of the genitalia]. Santti R; Mäkelä S; Pylkkänen L Duodecim; 1990; 106(18):1242-8. PubMed ID: 1670552 [No Abstract] [Full Text] [Related]
14. Dormant dangers of DES. Nevin MM Can Nurse; 1988 Mar; 84(3):17-9. PubMed ID: 3349433 [No Abstract] [Full Text] [Related]
15. DES: a living legacy what can nurses do about it? Lehmann A Can Nurse; 1983 Dec; 79(11):34-9. PubMed ID: 6556946 [No Abstract] [Full Text] [Related]
17. Uterine anomalies and future pregnancies. Ansbacher R Clin Perinatol; 1983 Jun; 10(2):295-304. PubMed ID: 6352141 [TBL] [Abstract][Full Text] [Related]
18. [Endocrine disruptor compounds and their role in the developmental programming of the reproductive axis]. Guzmán C; Zambrano E Rev Invest Clin; 2007; 59(1):73-81. PubMed ID: 17569302 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. McLachlan JA; Newbold RR; Bullock BC Cancer Res; 1980 Nov; 40(11):3988-99. PubMed ID: 7193511 [No Abstract] [Full Text] [Related]
20. Role of metabolic activation in the transplacental carcinogenicity of diethylstilbestrol. Metzler M Int J Biol Res Pregnancy; 1982; 3(3):103-7. PubMed ID: 7174140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]